Results 191 to 200 of about 22,351 (243)

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR). [PDF]

J Neurol
Monschein T, Untersteiner H, Ponleitner M, Krajnc N, Zrzavy T, Bsteh G, Rommer P, Kornek B, Enzinger C, Di Pauli F, Kraus J, Guger M, Leutmezer F, Berger T, Austrian MS Treatment Registry (AMSTR).   +14 more
europepmc   +1 more source

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity. [PDF]

Mult Scler
Sandgren S, Maceski AM, Benkert P, Einsiedler M, Schaedelin S, Oechtering J, Achtnichts L, Lalive PH, Müller S, Pot C, Heslegrave A, Hunt D, Lycke J, Hoepner R, Roth P, Gobbi C, Comabella M, Derfuss T, Derfuss T, Kappos L, Granziera C, Abdelhak A, Leppert D, Willemse EA, Zetterberg H, Kuhle J.   +25 more
europepmc   +1 more source

Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment. [PDF]

Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.   +8 more
europepmc   +1 more source

Neonatal sevoflurane exposure disrupts the lung-brain axis and drives microglial neuroinflammation and cognitive deficits. [PDF]

J Neuroinflammation
Liang L, Cao S, Zhao Y, Liu B, Wang J, Gong P, Wang Y, Hao G, ZhangMu X, Lu N, Zhang H, Wu S, Kuang F, Zhang H.   +13 more
europepmc   +1 more source

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies. [PDF]

Front Immunol
Aiello A, Navarra A, Haggiag S, Ruggieri S, Cuzzi G, Vanini V, Salmi A, Notari S, Altera AMG, Meschi S, Colavita F, Cimini E, Tortorella C, Prosperini L, Quartuccio ME, Galgani S, Puro V, Maggi F, Grifoni A, Sette A, Nicastri E, Gasperini C, Goletti D.   +22 more
europepmc   +1 more source